End-to-End Commercialization Build for a First-Launch Biotech

Integrated, tech-enabled commercialization spanning strategy, evidence, access, and engagement.

Client overview

An emerging biopharmaceutical company was preparing for a first global launch, with lean in-house commercialization capabilities and a need for integrated, end-to-end support.

Business challenge

• Limited internal commercial, access, and medical capacity during a high-intensity pre-launch window
• High-stakes decisions across key value inflection points, including positioning, evidence roadmap, payer readiness, and launch operating model
• Rapidly evolving competitive and stakeholder dynamics requiring alignment around a clear value story grounded in patient need

Our approach

• Embedded senior leader and cross-functional team to simplify activation, align stakeholders, and maintain a single operating cadence
• Integrated blueprint across strategy, evidence, access, and engagement focused on the key value inflection points that drive launch success
• Program management and readiness tracking enabled by Ignite to coordinate workstreams and accelerate decisions

Value delivered

Launch-ready roadmap anchored in a clear value story grounded in patient need and differentiated positioning choices

Governance and readiness model with decision rights, timelines, and metrics to reduce execution risk across priority markets

Stronger external confidence with a differentiated value narrative supported by fit-for-purpose evidence aligned to payer and HTA expectations